Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 2/20 | 0.70 |
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.62 |
| ▸ | LPL | P06858 | 8/20 | 0.62 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.39 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29688361 | 1.00 | DGAT1 (0.70) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL18015662 | 0.97 | DGAT1 (0.70) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL15747808 | 0.95 | DGAT1 (0.69) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21125909 | 0.92 | DGAT1 (0.67) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL18015663 | 0.90 | DGAT1 (0.59) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL29293266 | 0.89 | LIPG (0.71) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL21125910 | 0.89 | DGAT1 (0.57) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL793065 | 0.87 | DGAT1 (0.63) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL19933582 | 0.87 | DGAT1 (0.62) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20176546 | 0.87 | DGAT1 (0.56) | DGAT1LIPGLPLPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092053-A1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260055127-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | UDC IRELAND LTD (IE) | 2026-02-26 | — | — | US | disclosed |
| EP-4681774-A2 | KHK INHIBITORS | Gilead Sciences, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12479873-B2 | Metal complexes | UDC Ireland (IE) | 2025-11-25 | — | — | US | disclosed |
| EP-4313967-B1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12454542-B2 | Metal complexes for use as emitters in organic electroluminescence devices | UDC IRELAND LIMITED (IE) | 2025-10-28 | — | — | US | disclosed |
| US-12410160-B2 | KHK inhibitors | GILEAD SCIENCES, INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250268910-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | PHILIP MORRIS PRODUCTS S.A. (CH) | 2025-08-28 | — | — | US | disclosed |
| US-12127470-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-10-22 | — | — | US | disclosed |
| US-20240300989-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | UDC IRELAND LTD (IE) | 2024-09-12 | — | — | US | disclosed |
| US-20110065738-A1 | POLYCYCLIC GUANINE DERIVATIVES AND USE THEREOF | SCHERING CORPORATION | 2011-03-17 | — | — | US | disclosed |
| WO-2011002887-A1 | FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS | SCHERING CORPORATION (US) | 2011-01-06 | — | — | WO | disclosed |
| WO-2011002887-A1 | FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS | SCHERING CORPORATION (US) | 2011-01-06 | — | — | WO | disclosed |
| WO-2010118207-A1 | PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS | SCHERING CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010118207-A1 | PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS | SCHERING CORPORATION (US) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010027583-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010027583-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010028151-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010028151-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2009002423-A2 | POLYCYCLIC GUANINE DERIVATIVES AND USE THEREOF | SCHERING CORPORATION (US) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12454542-B2 | Metal complexes for use as emitters in organic electroluminescence devices | ICMT, ORAI2, AOC2 | DGAT1 2614/4885LIPG 4819/4885LPL 4753/4885 |
| US-12479873-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | DGAT1 2093/4885LIPG 3352/4885LPL 3378/4885 |
| US-20240300989-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | ICMT, ORAI2, AOC2 | DGAT1 2614/4885LIPG 4819/4885LPL 4753/4885 |
| US-12127470-B2 | Organic electroluminescent materials and devices | SOD1, CLTB, L1CAM | DGAT1 4690/4885LIPG 3545/4885LPL 3973/4885 |
| US-20260092053-A1 | KHK INHIBITORS | KHK, SLC5A2, HK1 | DGAT1 1085/4885LIPG 249/4885LPL 178/4885 |
| US-12410160-B2 | KHK inhibitors | KHK, KHDRBS1, NADK | DGAT1 3451/4885LIPG 2261/4885LPL 3327/4885 |
| US-20110065738-A1 | POLYCYCLIC GUANINE DERIVATIVES AND USE THEREOF | GDA, HPRT1, GMPS | DGAT1 1438/4885LIPG 4777/4885LPL 4817/4885 |
| US-20260055127-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | SCO2, ROS1, MT-CO1 | DGAT1 2560/4885LIPG 4604/4885LPL 4678/4885 |
| US-20250268910-A1 | NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | CHRNA1, CHRNG, CHRM3 | DGAT1 3640/4885LIPG 2872/4885LPL 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.